• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性胃食管腺癌肿瘤免疫微环境的异质性和演变。

Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma.

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University, Guangzhou, 510060, People's Republic of China.

Department of Gastric Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.

出版信息

Gastric Cancer. 2022 Nov;25(6):1017-1030. doi: 10.1007/s10120-022-01324-7. Epub 2022 Jul 29.

DOI:10.1007/s10120-022-01324-7
PMID:35904677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9587966/
Abstract

BACKGROUND

Tumour immune microenvironment heterogeneity is prevalent in numerous cancers and can negatively impact immunotherapy response. Immune heterogeneity and evolution in gastroesophageal adenocarcinoma (GEA) have not been studied in the past.

METHODS

Together with a multi-region sampling of normal, primary and metastatic tissues, we performed whole exome sequencing, TCR sequencing as well as immune cell infiltration estimation through deconvolution of gene expression signals.

RESULTS

We discovered high TCR repertoire and immune cell infiltration heterogeneity among metastatic sites, while they were homogeneous among primary and normal samples. Metastatic sites shared high levels of abundant TCR clonotypes with blood, indicating immune surveillance via blood. Metastatic sites also had low levels of tumour-eliminating immune cells and were undergoing heavy immunomodulation compared to normal and primary tumour tissues. There was co-evolution of neo-antigen and TCR repertoire, but only in patients with late diverging mutational evolution. Co-evolution of TCR repertoire and immune cell infiltration was seen in all except one patient.

CONCLUSIONS

Our findings revealed immune heterogeneity and co-evolution in GEA, which may inform immunotherapy decision-making.

摘要

背景

肿瘤免疫微环境异质性在许多癌症中普遍存在,并可能对免疫治疗反应产生负面影响。过去并未研究过胃食管腺癌(GEA)中的免疫异质性和进化。

方法

我们与正常、原发性和转移性组织的多区域采样一起,进行了全外显子测序、TCR 测序以及通过基因表达信号解卷积来估计免疫细胞浸润。

结果

我们发现转移性部位之间存在高 TCR 库和免疫细胞浸润异质性,而原发性和正常样本之间则具有同质性。转移性部位与血液共享高水平的丰富 TCR 克隆型,表明通过血液进行免疫监视。与正常和原发性肿瘤组织相比,转移性部位的肿瘤杀伤性免疫细胞水平较低,且正在进行强烈的免疫调节。新抗原和 TCR 库存在共同进化,但仅在发生晚期突变进化的患者中存在。除了一名患者外,所有患者均观察到 TCR 库和免疫细胞浸润的共同进化。

结论

我们的发现揭示了 GEA 中的免疫异质性和共同进化,这可能为免疫治疗决策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/9e35efd400a7/10120_2022_1324_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/dfab401b5c18/10120_2022_1324_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/9d76587fe92a/10120_2022_1324_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/3f5b0272c9da/10120_2022_1324_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/ee631eb62893/10120_2022_1324_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/9e35efd400a7/10120_2022_1324_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/dfab401b5c18/10120_2022_1324_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/9d76587fe92a/10120_2022_1324_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/3f5b0272c9da/10120_2022_1324_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/ee631eb62893/10120_2022_1324_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba79/9587966/9e35efd400a7/10120_2022_1324_Fig5_HTML.jpg

相似文献

1
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma.转移性胃食管腺癌肿瘤免疫微环境的异质性和演变。
Gastric Cancer. 2022 Nov;25(6):1017-1030. doi: 10.1007/s10120-022-01324-7. Epub 2022 Jul 29.
2
Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.食管鳞癌中 B 细胞受体库的克隆分布和肿瘤内异质性。
J Pathol. 2018 Nov;246(3):323-330. doi: 10.1002/path.5142. Epub 2018 Sep 19.
3
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.TCR repertoire 和 T 细胞激活的差异是抗肿瘤免疫反应在清除肿瘤宿主和进展肿瘤宿主中产生不同结果的基础。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001615.
4
Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma.立体定向体部放疗对非小细胞肺癌或肺转移癌的肿瘤基因组及肿瘤免疫微环境具有修饰作用。
Front Immunol. 2021 Jan 22;11:594212. doi: 10.3389/fimmu.2020.594212. eCollection 2020.
5
Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma.多组学研究揭示原发性肝癌中肿瘤浸润淋巴细胞的复杂性和空间异质性。
Oncotarget. 2017 May 23;8(21):34844-34857. doi: 10.18632/oncotarget.16758.
6
Case Report: Durable Complete Response After Combined Immunotherapy Following Resection of Primary Tumor in a Gallbladder Cancer Patient With Distant Metastatic Lymph Nodes of Favorable Immune-Microenvironment.病例报告:在具有有利免疫微环境的远处转移性淋巴结的胆囊癌患者中,在原发性肿瘤切除后联合免疫治疗实现持久完全缓解。
Front Immunol. 2022 Feb 15;13:820566. doi: 10.3389/fimmu.2022.820566. eCollection 2022.
7
Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade.接受放疗联合PD-1阻断治疗的食管鳞状细胞癌患者T细胞受体库的时空分析
Oncoimmunology. 2022 Jan 13;11(1):2025668. doi: 10.1080/2162402X.2022.2025668. eCollection 2022.
8
Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma.肺腺癌患者原发和转移部位的免疫基因组肿瘤间异质性。
J Exp Clin Cancer Res. 2022 May 11;41(1):172. doi: 10.1186/s13046-022-02361-x.
9
Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features.胰腺癌相关的肿瘤浸润 B 和 T 细胞 repertoire 与宿主和肿瘤特征有关。
Front Immunol. 2021 Sep 23;12:730746. doi: 10.3389/fimmu.2021.730746. eCollection 2021.
10
Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.多灶性肝细胞癌的异质性免疫基因组特征及独特逃逸机制
J Hepatol. 2020 May;72(5):896-908. doi: 10.1016/j.jhep.2019.12.014. Epub 2019 Dec 27.

引用本文的文献

1
Analysis of immune status and prognostic model incorporating lactic acid metabolism-associated genes.结合乳酸代谢相关基因的免疫状态分析及预后模型
Cancer Cell Int. 2024 Nov 14;24(1):378. doi: 10.1186/s12935-024-03555-3.
2
Significance of dysregulated M2 macrophage and in the ovarian metastasis of gastric cancer.M2巨噬细胞失调及[此处原文缺失部分内容]在胃癌卵巢转移中的意义。
Transl Cancer Res. 2024 Jun 30;13(6):2674-2690. doi: 10.21037/tcr-24-124. Epub 2024 Jun 20.
3
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer.

本文引用的文献

1
Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers.晚期胃食管腺癌的免疫检查点抑制剂耐药性。
Br J Cancer. 2021 Oct;125(8):1068-1079. doi: 10.1038/s41416-021-01425-7. Epub 2021 Jul 6.
2
The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.肿瘤内异质性在转移性非小细胞肺癌对免疫检查点抑制剂反应中的作用
Front Oncol. 2020 Dec 4;10:569202. doi: 10.3389/fonc.2020.569202. eCollection 2020.
3
Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1.
树突状细胞为基础的免疫治疗在接受手术切除的胰腺癌患者中的应用。
J Clin Oncol. 2024 Sep 10;42(26):3083-3093. doi: 10.1200/JCO.23.02585. Epub 2024 Jul 1.
4
Implications of the Organ-Specific Immune Environment for Immune Priming Effect of Radiotherapy in Metastatic Setting.器官特异性免疫环境对转移性放疗免疫原性效应的影响。
Biomolecules. 2023 Apr 18;13(4):689. doi: 10.3390/biom13040689.
联合 TCR 文库谱和血细胞表型预测黑色素瘤患者对个体化新抗原治疗联合抗 PD-1 的反应。
Cell Rep Med. 2020 Nov 17;1(8):100141. doi: 10.1016/j.xcrm.2020.100141.
4
Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.与免疫检查点治疗反应成功相关的 TCR 库特征。
Front Immunol. 2020 Oct 14;11:587014. doi: 10.3389/fimmu.2020.587014. eCollection 2020.
5
Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients.胃癌患者原发灶和转移灶中的肿瘤免疫微环境存在差异。
Sci Rep. 2020 Aug 31;10(1):14293. doi: 10.1038/s41598-020-71340-z.
6
Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.新抗原预测及临床获益的计算视角:来自 ESMO 精准医学工作组的建议。
Ann Oncol. 2020 Aug;31(8):978-990. doi: 10.1016/j.annonc.2020.05.008. Epub 2020 Jun 28.
7
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.解析晚期卵巢癌肿瘤免疫异质性揭示化疗的免疫原性效应。
Nat Genet. 2020 Jun;52(6):582-593. doi: 10.1038/s41588-020-0630-5. Epub 2020 Jun 1.
8
Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy.分子 T 细胞 repertoire 分析作为免疫检查点阻断治疗的预后和预测生物标志物的来源。
Int J Mol Sci. 2020 Mar 30;21(7):2378. doi: 10.3390/ijms21072378.
9
T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma.在接受免疫治疗前后,T 细胞受体库的特征与间皮瘤的临床反应相关。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000251.
10
Comprehensive T cell repertoire characterization of non-small cell lung cancer.非小细胞肺癌的全面 T 细胞受体谱特征。
Nat Commun. 2020 Jan 30;11(1):603. doi: 10.1038/s41467-019-14273-0.